Korea Bizwire, Author at Be Korea-savvy | Page 98 of 1081
Stricter Mortgage Rules Push Four Major Financial Groups Into Lower Interest Earnings

Stricter Mortgage Rules Push Four Major Financial Groups Into Lower Interest Earnings

SEOUL, Dec. 7 (Korea Bizwire) — Four major financial firms will likely see their interest income decrease for the first time since 2020 this year due to tighter lending rules aimed at curbing surging housing prices, data showed Sunday. KB Financial Group, Shinhan Financial Group, Hana Financial Group and Woori Financial Group are expected to [...]

U.S. and China Drop ‘Denuclearization of the Korean Peninsula’ From Key Security Documents, Prompting New Questions in Seoul

U.S. and China Drop ‘Denuclearization of the Korean Peninsula’ From Key Security Documents, Prompting New Questions in Seoul

SEOUL, Dec. 6 (Korea Bizwire) — Both the United States and China have quietly omitted references to the “denuclearization of the Korean Peninsula” from major national security documents released in recent weeks, raising speculation over whether the two most influential actors in nuclear diplomacy with Pyongyang are recalibrating their approach. The omission in Washington was notable. [...]

Government to Tighten Screening of Information Security System Following Coupang Breach

Government to Tighten Screening of Information Security System Following Coupang Breach

SEOUL, Dec. 6 (Korea Bizwire) — The government unveiled plans Saturday to toughen the management and screening process for the state-certified information security system amid growing personal data breaches at authorized companies, such as Coupang. The Personal Information Protection Commission and the Ministry of Science and ICT discussed the measures during an interagency meeting earlier [...]

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company’s RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company’s RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma

SPRING, Texas, Dec. 06, 2025 (Korea Bizwire) – Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today collaborative presentations at the 67th American Society of Hematology Annual Meeting and Exposition, in Orlando, Florida; with scientists from the Duke University School of Medicine in Durham, North Carolina; reporting data from preclinical studies [...]

New U.S. Security Strategy Raises Questions for Seoul as Washington Recasts Priorities

New U.S. Security Strategy Raises Questions for Seoul as Washington Recasts Priorities

SEOUL, Dec. 6 (Korea Bizwire) —  A sweeping shift in American national security priorities — from reasserting influence in the Western Hemisphere to elevating Taiwan’s defense and omitting North Korea’s denuclearization — is prompting fresh debate in Seoul over what the changes signal for South Korea’s security role in Asia. The White House on Thursday [...]

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus chemotherapy as 1st-line treatment for R/M NPC, achieving mOS of 64.8 months and a 5-year OS rate of 52.3%. Torpalimab plus chemotherapy has been approved in over 40 countries, representing the new standard of care for the 1st line treatment [...]

Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis

Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis

SHANGHAI, Dec. 05, 2025 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the new drug application (“NDA”) for the company’s product, roconkibart injection (a recombinant humanized anti-IL-17A monoclonal antibody injection, product code: [...]

Yachting: Monaco, 7th ‘Superyacht Chef Competition’ opens for entries

Yachting: Monaco, 7th ‘Superyacht Chef Competition’ opens for entries

MONACO, Dec. 05, 2025 (Korea Bizwire) – Preparations are underway at the Yacht Club de Monaco, which has opened applications for the 7th ‘Superyacht Chef Competition’, organised with Bluewater and scheduled for 2 April 2026. The initiative, led by La Belle Classe Academy, places the spotlight on chefs who shape the onboard experience on superyachts, [...]

Bitget Releases Major Upgrades to GetAgent With Smarter Responses and Free Access for All Users

Bitget Releases Major Upgrades to GetAgent With Smarter Responses and Free Access for All Users

VICTORIA, Seychelles, Dec. 05, 2025 (Korea Bizwire) – Bitget, the world’s largest Universal Exchange (UEX), today announced a major upgrade to GetAgent, its AI-powered trading assistant. The update introduces a more flexible answering engine, a streamlined user interface, and a significant expansion of membership quotas, making advanced AI trading tools more accessible than ever to users across all tiers. GetAgent, [...]